Related Experiment Video
Updated: Mar 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis 2015: Burden, Challenges and Strategy for Control and Elimination
Mario Raviglione1, Giorgia Sulis2
1Global Tuberculosis Programme, World Health Organization , Geneva, Switzerland.
Tuberculosis (TB) remains a global health crisis, disproportionately affecting vulnerable populations. New strategies aim for significant reductions in TB cases and deaths by 2030, requiring global commitment and research investment.
Area of Science:
- Public Health
- Infectious Diseases
- Global Health
Background:
- Tuberculosis (TB) is a major global cause of illness and death, with 9.6 million new cases and 1.5 million deaths annually.
- Socially excluded and impoverished groups bear the highest TB burden, necessitating interventions addressing social determinants of health.
- The rise of multidrug-resistant TB underscores the urgent need for advancements in diagnostics, drugs, and vaccines.
Purpose of the Study:
- To review the global TB landscape and the progress made in combating the disease.
- To highlight the targets of the World Health Organization's end-TB strategy and its alignment with Sustainable Development Goals.
- To emphasize the critical factors required for achieving global TB elimination.
Main Methods:
- Review of global TB statistics and trends.
- Analysis of the World Health Organization's end-TB strategy and its objectives.
- Identification of key requirements for TB control and elimination.
Main Results:
- The end-TB strategy aims for a 90% reduction in TB mortality and an 80% decrease in incidence by 2030.
- The strategy also targets the elimination of catastrophic expenditures for individuals affected by TB.
- Significant progress has been made, but substantial challenges remain in achieving global TB elimination.
Conclusions:
- Achieving the ambitious goals of the end-TB strategy requires strong government commitment, adequate financing, and community engagement.
- Sustained and increased investment in TB research is crucial for developing new tools and strategies.
- Addressing social determinants of health and focusing on high-risk populations are essential for TB control.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

